IBDEI0RL ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,12421,1,4,0)
;;=4^E11.311
;;^UTILITY(U,$J,358.3,12421,2)
;;=^5002632
;;^UTILITY(U,$J,358.3,12422,0)
;;=E11.319^^49^600^22
;;^UTILITY(U,$J,358.3,12422,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12422,1,3,0)
;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,12422,1,4,0)
;;=4^E11.319
;;^UTILITY(U,$J,358.3,12422,2)
;;=^5002633
;;^UTILITY(U,$J,358.3,12423,0)
;;=E11.40^^49^600^11
;;^UTILITY(U,$J,358.3,12423,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12423,1,3,0)
;;=3^DM Type 2 w/ Diabetic Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,12423,1,4,0)
;;=4^E11.40
;;^UTILITY(U,$J,358.3,12423,2)
;;=^5002644
;;^UTILITY(U,$J,358.3,12424,0)
;;=E11.41^^49^600^10
;;^UTILITY(U,$J,358.3,12424,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12424,1,3,0)
;;=3^DM Type 2 w/ Diabetic Mononeuropathy
;;^UTILITY(U,$J,358.3,12424,1,4,0)
;;=4^E11.41
;;^UTILITY(U,$J,358.3,12424,2)
;;=^5002645
;;^UTILITY(U,$J,358.3,12425,0)
;;=E11.42^^49^600^14
;;^UTILITY(U,$J,358.3,12425,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12425,1,3,0)
;;=3^DM Type 2 w/ Diabetic Polyneuropathy
;;^UTILITY(U,$J,358.3,12425,1,4,0)
;;=4^E11.42
;;^UTILITY(U,$J,358.3,12425,2)
;;=^5002646
;;^UTILITY(U,$J,358.3,12426,0)
;;=E11.43^^49^600^8
;;^UTILITY(U,$J,358.3,12426,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12426,1,3,0)
;;=3^DM Type 2 w/ Diabetic Autonomic Polyneuropathy
;;^UTILITY(U,$J,358.3,12426,1,4,0)
;;=4^E11.43
;;^UTILITY(U,$J,358.3,12426,2)
;;=^5002647
;;^UTILITY(U,$J,358.3,12427,0)
;;=E11.51^^49^600^12
;;^UTILITY(U,$J,358.3,12427,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12427,1,3,0)
;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,12427,1,4,0)
;;=4^E11.51
;;^UTILITY(U,$J,358.3,12427,2)
;;=^5002650
;;^UTILITY(U,$J,358.3,12428,0)
;;=E11.52^^49^600^13
;;^UTILITY(U,$J,358.3,12428,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12428,1,3,0)
;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,12428,1,4,0)
;;=4^E11.52
;;^UTILITY(U,$J,358.3,12428,2)
;;=^5002651
;;^UTILITY(U,$J,358.3,12429,0)
;;=E11.621^^49^600^15
;;^UTILITY(U,$J,358.3,12429,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12429,1,3,0)
;;=3^DM Type 2 w/ Foot Ulcer
;;^UTILITY(U,$J,358.3,12429,1,4,0)
;;=4^E11.621
;;^UTILITY(U,$J,358.3,12429,2)
;;=^5002656
;;^UTILITY(U,$J,358.3,12430,0)
;;=E11.641^^49^600^17
;;^UTILITY(U,$J,358.3,12430,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12430,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,12430,1,4,0)
;;=4^E11.641
;;^UTILITY(U,$J,358.3,12430,2)
;;=^5002661
;;^UTILITY(U,$J,358.3,12431,0)
;;=E11.649^^49^600^18
;;^UTILITY(U,$J,358.3,12431,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12431,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,12431,1,4,0)
;;=4^E11.649
;;^UTILITY(U,$J,358.3,12431,2)
;;=^5002662
;;^UTILITY(U,$J,358.3,12432,0)
;;=E78.01^^49^600^24
;;^UTILITY(U,$J,358.3,12432,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12432,1,3,0)
;;=3^Familial Hypercholesterolemia
;;^UTILITY(U,$J,358.3,12432,1,4,0)
;;=4^E78.01
;;^UTILITY(U,$J,358.3,12432,2)
;;=^7570555
;;^UTILITY(U,$J,358.3,12433,0)
;;=E78.00^^49^600^33
;;^UTILITY(U,$J,358.3,12433,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12433,1,3,0)
;;=3^Pure Hypercholesterolemia,Unspec
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0RL 3777 printed Apr 09, 2024@21:48:44 Page 2
IBDEI0RL ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,12421,1,4,0)
+2 ;;=4^E11.311
+3 ;;^UTILITY(U,$J,358.3,12421,2)
+4 ;;=^5002632
+5 ;;^UTILITY(U,$J,358.3,12422,0)
+6 ;;=E11.319^^49^600^22
+7 ;;^UTILITY(U,$J,358.3,12422,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,12422,1,3,0)
+10 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/o Macular Edema
+11 ;;^UTILITY(U,$J,358.3,12422,1,4,0)
+12 ;;=4^E11.319
+13 ;;^UTILITY(U,$J,358.3,12422,2)
+14 ;;=^5002633
+15 ;;^UTILITY(U,$J,358.3,12423,0)
+16 ;;=E11.40^^49^600^11
+17 ;;^UTILITY(U,$J,358.3,12423,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,12423,1,3,0)
+20 ;;=3^DM Type 2 w/ Diabetic Neuropathy,Unspec
+21 ;;^UTILITY(U,$J,358.3,12423,1,4,0)
+22 ;;=4^E11.40
+23 ;;^UTILITY(U,$J,358.3,12423,2)
+24 ;;=^5002644
+25 ;;^UTILITY(U,$J,358.3,12424,0)
+26 ;;=E11.41^^49^600^10
+27 ;;^UTILITY(U,$J,358.3,12424,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,12424,1,3,0)
+30 ;;=3^DM Type 2 w/ Diabetic Mononeuropathy
+31 ;;^UTILITY(U,$J,358.3,12424,1,4,0)
+32 ;;=4^E11.41
+33 ;;^UTILITY(U,$J,358.3,12424,2)
+34 ;;=^5002645
+35 ;;^UTILITY(U,$J,358.3,12425,0)
+36 ;;=E11.42^^49^600^14
+37 ;;^UTILITY(U,$J,358.3,12425,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,12425,1,3,0)
+40 ;;=3^DM Type 2 w/ Diabetic Polyneuropathy
+41 ;;^UTILITY(U,$J,358.3,12425,1,4,0)
+42 ;;=4^E11.42
+43 ;;^UTILITY(U,$J,358.3,12425,2)
+44 ;;=^5002646
+45 ;;^UTILITY(U,$J,358.3,12426,0)
+46 ;;=E11.43^^49^600^8
+47 ;;^UTILITY(U,$J,358.3,12426,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,12426,1,3,0)
+50 ;;=3^DM Type 2 w/ Diabetic Autonomic Polyneuropathy
+51 ;;^UTILITY(U,$J,358.3,12426,1,4,0)
+52 ;;=4^E11.43
+53 ;;^UTILITY(U,$J,358.3,12426,2)
+54 ;;=^5002647
+55 ;;^UTILITY(U,$J,358.3,12427,0)
+56 ;;=E11.51^^49^600^12
+57 ;;^UTILITY(U,$J,358.3,12427,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,12427,1,3,0)
+60 ;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/o Gangrene
+61 ;;^UTILITY(U,$J,358.3,12427,1,4,0)
+62 ;;=4^E11.51
+63 ;;^UTILITY(U,$J,358.3,12427,2)
+64 ;;=^5002650
+65 ;;^UTILITY(U,$J,358.3,12428,0)
+66 ;;=E11.52^^49^600^13
+67 ;;^UTILITY(U,$J,358.3,12428,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,12428,1,3,0)
+70 ;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/ Gangrene
+71 ;;^UTILITY(U,$J,358.3,12428,1,4,0)
+72 ;;=4^E11.52
+73 ;;^UTILITY(U,$J,358.3,12428,2)
+74 ;;=^5002651
+75 ;;^UTILITY(U,$J,358.3,12429,0)
+76 ;;=E11.621^^49^600^15
+77 ;;^UTILITY(U,$J,358.3,12429,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,12429,1,3,0)
+80 ;;=3^DM Type 2 w/ Foot Ulcer
+81 ;;^UTILITY(U,$J,358.3,12429,1,4,0)
+82 ;;=4^E11.621
+83 ;;^UTILITY(U,$J,358.3,12429,2)
+84 ;;=^5002656
+85 ;;^UTILITY(U,$J,358.3,12430,0)
+86 ;;=E11.641^^49^600^17
+87 ;;^UTILITY(U,$J,358.3,12430,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,12430,1,3,0)
+90 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
+91 ;;^UTILITY(U,$J,358.3,12430,1,4,0)
+92 ;;=4^E11.641
+93 ;;^UTILITY(U,$J,358.3,12430,2)
+94 ;;=^5002661
+95 ;;^UTILITY(U,$J,358.3,12431,0)
+96 ;;=E11.649^^49^600^18
+97 ;;^UTILITY(U,$J,358.3,12431,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,12431,1,3,0)
+100 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
+101 ;;^UTILITY(U,$J,358.3,12431,1,4,0)
+102 ;;=4^E11.649
+103 ;;^UTILITY(U,$J,358.3,12431,2)
+104 ;;=^5002662
+105 ;;^UTILITY(U,$J,358.3,12432,0)
+106 ;;=E78.01^^49^600^24
+107 ;;^UTILITY(U,$J,358.3,12432,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,12432,1,3,0)
+110 ;;=3^Familial Hypercholesterolemia
+111 ;;^UTILITY(U,$J,358.3,12432,1,4,0)
+112 ;;=4^E78.01
+113 ;;^UTILITY(U,$J,358.3,12432,2)
+114 ;;=^7570555
+115 ;;^UTILITY(U,$J,358.3,12433,0)
+116 ;;=E78.00^^49^600^33
+117 ;;^UTILITY(U,$J,358.3,12433,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,12433,1,3,0)
+120 ;;=3^Pure Hypercholesterolemia,Unspec
